In a press conference this morning, Allarae Healthcare Incorporated announced that it has selected Gary Wald and his company, Incubator Partners, as its marketing and distribution consultant. Allarae is an international developer and distributor of advanced biotechnology and personal health screening products. Allarae’s monitoring kits include screenings for influenza, breast cancer, strep throat and prostate cancer. In the near future, the company anticipates distributing HIV, hepatitis, malaria and heart disease screening products.
The new partnership with Incubator products is the next logical step for Allarae to meet its goal of $10-$20 million in sales by the year 2010. Incubator Partners has proven itself as a premier marketing and business development consulting firm in just five short years. A lot of Incubator Partner’s success has been attributed to Mr. Wald’s hard work and dedication to the company. Phil Matteis, CEO of Allarae HealthCare said, “We selected Gary Wald, after a long evaluation period, because of his extensive experience in marketing healthcare products and services to consumers, physicians and managed care companies.”
In addition to starting and running a successful firm, Mr. Wald holds an MBA in marketing from Northwestern University. Prior to branching out on his own and founding Incubator Partners, Wald worked for several major advertising agencies, including Ogilvy & Mather and Grey Advertising. During his employment with these agencies, he has had many notable successes, including the launch of Aim Toothpaste, the re-branding of Dove soap, the introduction of the “Transformers” toy series and the subsequent build into one of the industry’s most successful toy brands, the licensing of both “Transformers” and “G.I. Joe” television programs to broadcasters around the world, the launch of CNBC as a worldwide brand, and the subscriber growth and generation of licensing revenue for GTE’s (now Verizon) cable TV and Internet divisions.
Working for Allarae will be a smaller and more intimate experience, where Wald will focus his efforts on revenue and profit growth as well as building a world-class brand. These goals should not be hard to obtain, since Allarae has been creating and developing help-monitoring supplies for over 11 years. The company also has a considerable time and technology advantage over its new competitors, one that will likely last for several years provide first-to-market status via many innovative monitoring and detection solutions. With the proven experience and success of Mr. Wald and Incubator Products, the $10 million minimum sales goal for Allarae could be a very low floor.
Let us hear your thoughts: Allarae Healthcare, Inc. Message Board